The ASAM Pain & Addiction Essentials Online - Module 2: Stigma

5 (3 votes)

  • Register
    • Non-Member - $39
    • Regular Member - $29
    • Retired - $19
    • Early Career Physician - $29
    • Resident - $19
    • Student - $19
    • Associate - $19
    • ASAM Staff - Free!
    • International Member - $29
    • Emeritus Member - $29
    • Provisional Member - $29
    • Fellow Member - $29
    • Honorary Member - $29
    • CRT Member - $29

The ASAM Pain & Addiction Essentials Online - Module 2: Stigma

On-Demand Module

Overview

This 1-hour on-demand module covers different types of stigma that may affect patients seeking treatment for pain or substance use disorder, including structural stigma, social stigma, and self-stigma and how to mitigate stigma.

This module is part of The ASAM Pain & Addiction Essentials, a series of 6 online modules (rolled out throughout 2021) that cover the foundations of pain and addiction including the science, stigma, screening and assessment, treatment, and interdisciplinary approaches. All modules can be taken together as a full 6-hour course or can be taken individually to fill learner knowledge gaps in pain and addiction topics. 

Learners looking for more advanced topics in pain and addiction should register for The ASAM Pain & Addiction: Common Threads Course which takes place annually.

The target audience for this module includes: primary care physicians, fellows in training and residents, providers who are new to addiction medicine or are early in their career and other members of the care team who are looking for introductory topics on pain and addiction.

This session addresses the following ACGME Competencies: Medical Knowledge, Systems Based Practice. 

Learning Objectives

Upon completion, learners will be able to:

  1. Define the types of stigma that may affect patients seeking treatment for pain or substance use disorder, including structural stigma, social stigma, and self-stigma
  2. Examine the impact that the stigma associated with substance use disorder and chronic pain has on individuals, especially as a deterrent to seeking or continuing treatment
  3. Recognize how bias and discrimination based on race, gender, sexual orientation, age, ethnicity, and other qualities may influence patient outcomes in people seeking treatment for pain and substance use disorder
  4. Recognize how common, stigmatizing language regarding addiction and pain treatment can affect people's perceptions of substance use disorder or chronic pain conditions
  5. Identify ways to address and mitigate stigma, especially through the use of non-stigmatizing language

Fees

Rate DescriptionRate
ASAM Member$29
Non-Member$39
Associate Member$19
Resident Member*$19
Student Member*$19

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 06/10/2024

Course Instructions

  1. Click the "Contents" tab and select "View On-Demand Recording".  After viewing the entire video, return to the Contents tab.
  2. Click "Complete Post Test" to answer quiz questions. You will have 10 attempts and must get at least 2 out of 3 questions correct. After completing the quiz, return to the Contents tab. 
  3. Click "Complete Evaluation" to answer evaluation questions. Scroll down on all questions, there are answers that expand past the size of the window. 
  4. Click the button “Claim Credits” in the box titled “Claim Credits & Certificate." Choose the type of credit and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

Need Assistance?

If you have are experiencing any log in issues, cannot access a course, need assistance claiming credit, or have other questions or concerns, please e-mail Education@asam.org for assistance.

For learners who may have difficulty typing, moving a mouse or reading, Essential Accessibility is an application available for use to assist.

Donald R. Teater

MD, MPH

Don Teater MD, MPH is a family physician who has worked in western North Carolina for the past 30 years. Since 2004 he has focused on the intersection of pain, opioids, and addiction. Don was the lead facilitator for the expert panel during the development of the CDC Guidelines for Prescribing Opioids for Chronic Pain.

From 2013-2016, Don was the Medical Advisor at the National Safety Council leading their effort to reduce opioid abuse and overdose in the community and in the workplace. He continues to work with federal and state government organizations, medical organizations and nonprofits in addressing many aspects of the opioid epidemic.

While working on the public health aspects of the opioid epidemic, he sees patients one day a week treating opioid use disorder and chronic pain in Waynesville, NC by telemedicine. He also works one week each month as a pain and addiction specialist seeing Alaska Native patients with the SouthEast Alaska Regional Health Consortium (SEARHC) in Juneau, AK.

No Relevant Financial Disclosures

Sarah Wakeman

MD

Sarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, Medical Director for Substance Use Disorder at Mass General Brigham, and an Associate Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, and co-chair of the Mass General Brigham Substance Use Steering Committee. 

She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine and board certified in Addiction Medicine by the American Board of Preventive Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she serves on the American Society of Addiction Medicine Ethics Committee.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, low threshold treatment models, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care. 

Anika Alvanzo

MD, MS, DFASAM, FACP

Anika Alvanzo, MD, MS, DFASAM, FACP is the Eastern Region Medical Director for Pyramid Healthcare, Inc. She also serves as a physician consultant on substance use disorders to the Behavioral Health Administration in the Maryland Department of Health and is the Managing Partner of Uzima Consulting Group, LLC, which provides addiction medicine-related consultation, education and training, and expert witness testimony. Dr. Alvanzo is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and Addiction Medicine. Dr. Alvanzo is a Distinguished Fellow of ASAM, a Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM), and currently serves as Chair of the ASAM Annual Conference Program Planning Committee and Region V Director for the ASAM Board of Directors.

At Pyramid Healthcare, Inc., Dr. Alvanzo’s role is to optimize and standardize the medical care, with emphasis on substance withdrawal management and pharmacotherapy, in the residential and outpatient addiction treatment programs in Eastern Pennsylvania and Maryland. Prior to this, Dr. Alvanzo spent twelve years as faculty in the Divisions of General Internal Medicine and Addiction Medicine at Johns Hopkins University School of Medicine where she held a variety of clinical leadership roles, including Associate Medical Director of Addiction Treatment Services and the Center for Addiction and Pregnancy and Medical Director of the Broadway Center for Addiction, comprehensive, outpatient substance use disorder treatment (SUD) programs on the Johns Hopkin Bayview and Johns Hopkins Hospital campuses, respectively. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service serving the Johns Hopkins Hospital Department of Medicine general and subspecialty services.

Dr. Alvanzo has served as an expert on National Institutes of Health (NIH), Substance Abuse and Mental Health Services Administration (SAMHSA), National Academies of Sciences, Engineering and Medicine (NASEM), National Quality Forum (NQF) and PEW Research Center panels regarding opioids and integration of recovery-oriented care in various medical settings. 

Matthew Tierney

APRN

Matt Tierney, APRN is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.

No relevant financial disclosures

CME, CE, CEU and Other Credit Types


ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

National Board for Certified Counselors ACEP

The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification


American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

Royal College of Physicians and Surgeons of Canada (RCPSC)

Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

Disclosure Information


Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ASAM CME Committee Reviewer

Benjamin Bearnot, MD – Does disclose

  • We The Village, Inc, Clinical Condition: Opioid Use Disorder, CRAFT support, Consultant/Advisory Board
  • Halcyon Health, Clinical Condition: Opioid Use Disorder, Recovery Coaching, Consultant/Advisory Board
Faculty and Planning Committee

Donald R. Teater, MD, MPH – No Relevant Financial Disclosures 
Denver, CO

Anika Alvanzo, MD, MS, FACP, DFASAM - No Relevant Financial Disclosures 
Baltimore, MD

Matthew Tierney, ANP, PMHNP, CARN-AP, FAAN – No Relevant Financial Disclosures 
San Francisco, CA

Sarah Wakeman, MD – Does disclose
Charlestown, MA

  • Celero Systems (Consultant/Advisory Board)
  • Springer Textbook (Other Research Support includes receipt of drugs, supplies, equipment or other in-kind support, Textbook royalties)
  • UpToDate (Speaker/Honoraria includes speakers bureau, symposia, and expert witness)
Planning Committee Disclosure Information

William S. Jacobs, MD (Chair) – No Relevant Financial Disclosures
Saint Johns, FL

Gregory Rudolf, MD (Vice-Chair) – No Relevant Financial Disclosures
Seattle, WA

Mark Weiner, MD, DFASAM (Immediate Past Chair) – No Relevant Financial Disclosures
Ann Arbor, MI

Harithsa S. Asuri, MD – No Relevant Financial Disclosures
Cincinnati, OH

Gregory X. Boehm, MD, DFASAM – No Relevant Financial Disclosures
Shaker Heights, OH

Denise Josey, MD, MPH, MS – No Relevant Financial Disclosures
Lake Worth, FL

Laura Morgan Frankart, PharmD, MEd, BCPS – No Relevant Financial Disclosures
Richmond, VA

Launette Marie Rieb, MD, MSc, CCFP, FCFP, FASAM – No Relevant Financial Disclosures
Vancouver, BC

Donald R. Teater, MD, MPH – No Relevant Financial Disclosures 
Denver, CO

Michael P. Sprintz, DO, DFASAM – Dose Disclose 
Shenandoah, TX

  • Cellarian, Inc, Clinical Condition: Diagnostic Toxicology, SUD, COVID-19, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property)
  • FirsTox, LLC, Clinical Condition: Drug Testing, Consultant/Advisory Board, Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  • Saluda Medical, Clinical Condition: Pain Management, Consultant/Advisory Board
  • Mahantech, Clinical Condition: PDMP for SUD identification, Consultant/Advisory Board
  • Dean Law firm, Clinical Condition: Pain management, Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  • Texas Pain Society, Clinical Condition: Pain and addiction, Speaker honoraria
  • Texas A&M University Health Center, Clinical Condition: Pain and addiction, Speaker honoraria

All relevant financial relationships have been mitigated

Key:

Complete
Failed
Available
Locked
Complete Module 2: Stigma
Begin self-paced component package.
Begin self-paced component package. This module will take between 55-60 minutes to complete.
Complete Post Test
3 Questions  |  10 attempts  |  2/3 points to pass
3 Questions  |  10 attempts  |  2/3 points to pass This post test has 3 questions and requires 2 out of 3 to pass the test.
Complete Evaluation
14 Questions
14 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credits & Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Attendees should claim only the credit commensurate with the extent of their participation in the activity.